SCPC Applauds Senate Judiciary Committee for Spotlighting PBM Anticompetitive Behavior, Urges Immediate Action on PBM Reform
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement thanking Senate Judiciary Chairman Chuck Grassley and members of the Committee for prioritizing pharmacy benefit manager (PBM) reform during today’s hearing, “PBM Power Play: Examining Competition Issues in the Prescription Drug Supply Chain.”
“PBMs have long exploited a broken and opaque drug pricing system, leveraging excessive markups and vertical integration to consolidate market power and boost profits to the detriment of patients and the LTC pharmacies that serve them. SCPC continues to urge Congress to pass legislation that immediately brings transparency and accountability to PBM practices.
“We applaud Chairman Grassley and the Committee for shedding light on the anticompetitive behavior of PBMs, which has allowed three dominant companies to dictate when, where, and how most Americans access their medications—and at what cost. At the same time, PBMs are imposing unfair contracts and unsustainable reimbursement rates on long-term care (LTC) pharmacies, which are already grappling with the looming threat of closures due to Medicare Part D price negotiations that take effect in January 2026.
“PBM reform is urgent. Without action, many nursing homes and other LTC facilities across the country will lose access to LTC pharmacies that provide essential, around-the-clock care to seniors and other vulnerable populations. Any PBM reform must include LTC-specific provisions to give CMS the authority to enforce fair contracts and transparent pricing. We call on Congress to build on the momentum of today’s hearing and pass comprehensive PBM reform that protects LTC patients and providers,” said Alan Rosenbloom, President and CEO of SCPC.
###
Recent Posts
-
Bill Aims to Offset Reimbursement Losses for Long-Term Care Pharmacies Catering to Nursing Homes
Starting in January, falling prices for costly drugs may strain long-term care pharmacies, but proposed legislation backed by advocacy groups aims to subsidize some of this loss. And nursing home advocacy groups are among those urging Congress to pass the Preserving Patient Access to Long-Term Care Pharmacies Act.
-
Drug pricing policy could jeopardize long-term care pharmacies, leaders contend
Senior living and care leaders have joined a coalition calling attention to a policy fix they say would address unintended consequences of Medicare Part D price negotiations that could shutter long-term care pharmacies.
-
Senior Care Pharmacy Coalition: Passing HR 5031 Vital for Seniors’ Medication Access
The American Health Care Association/National Center for Assisted Living (AHCA/NCAL), LeadingAge, and Argentum joined the Senior Care Pharmacy Coalition (SCPC) in calling for Congress to pass the Preserving Patient Access to Long-Term Care Pharmacies Act (HR5031), according to a news release.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.